Alaunos Therapeutics, Inc. (TCRT): Operating Income
-$4.22M
Year ended 2025-12-31
-$4.06M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$4.22M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$4.81M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$34.27M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$35.10M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$77.55M | n/m | 2023-03-07, From 2021-01-01 |
| 2020-12-31 | -$80.36M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$57.86M | n/m | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | -$53.91M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$53.49M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$165.31M | n/m | 2019-03-05, From 2016-01-01 |
| 2015-12-31 | -$120.10M | n/m | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | -$43.50M | n/m | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | -$57.71M | n/m | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | -$102.17M | n/m | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | -$71.40M | n/m | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | -$24.55M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$12.12M | n/a | 2012-02-29, From 2009-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$4.22M | n/m |
| One World Products, Inc. (OWPC) | 2024-12-31 | -$1.87M | n/m |
| Aspire Biopharma Holdings, Inc. (ASBP) | 2025-12-31 | -$19.35M | n/m |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$19.57M | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$33.21M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$5.12M | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$1.04M | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$496.3K | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$8.91M | n/m |
Compare TCRT, OWPC, ASBP, ADTX side by side · Screen every company in Pharmaceutical Preparations ↗